Basilea Pharmaceutica Ag Stock Technical Analysis
| BPMUF Stock | USD 52.83 0.00 0.00% |
As of the 27th of November, Basilea Pharmaceutica shows the Mean Deviation of 0.0914, standard deviation of 0.377, and Risk Adjusted Performance of 0.0838. Basilea Pharmaceutica technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Basilea Pharmaceutica risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Basilea Pharmaceutica is priced correctly, providing market reflects its regular price of 52.83 per share. Given that Basilea Pharmaceutica has variance of 0.1421, we suggest you to validate Basilea Pharmaceutica AG's prevailing market performance to make sure the company can sustain itself at a future point.
Basilea Pharmaceutica Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Basilea, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BasileaBasilea |
Basilea Pharmaceutica technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Basilea Pharmaceutica Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Basilea Pharmaceutica volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Basilea Pharmaceutica Trend Analysis
Use this graph to draw trend lines for Basilea Pharmaceutica AG. You can use it to identify possible trend reversals for Basilea Pharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Basilea Pharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Basilea Pharmaceutica Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Basilea Pharmaceutica AG applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Basilea Pharmaceutica AG will continue generating value for investors. It has 122 observation points and a regression sum of squares at 55.64, which is the sum of squared deviations for the predicted Basilea Pharmaceutica price change compared to its average price change.About Basilea Pharmaceutica Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Basilea Pharmaceutica AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Basilea Pharmaceutica AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Basilea Pharmaceutica price pattern first instead of the macroeconomic environment surrounding Basilea Pharmaceutica. By analyzing Basilea Pharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Basilea Pharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Basilea Pharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.
Basilea Pharmaceutica November 27, 2024 Technical Indicators
Most technical analysis of Basilea help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Basilea from various momentum indicators to cycle indicators. When you analyze Basilea charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0838 | |||
| Market Risk Adjusted Performance | 1.34 | |||
| Mean Deviation | 0.0914 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 0.377 | |||
| Variance | 0.1421 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | 0.0331 | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | 1.33 | |||
| Maximum Drawdown | 3.06 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Complementary Tools for Basilea Pink Sheet analysis
When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |